{
  "ptid_time": "073_S_2190_2013-03-19",
  "img_path": "/data/qiuhui/data/adni/images/073_S_2190/2013-03-19/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 55,432 mm³, 17.9% above the reference mean. With a Z-score of 0.52 (69.8th percentile), this represents normal volume ; hippocampal volume measures 6,156 mm³, 11.7% below the reference mean. With a Z-score of -1.01 (15.7th percentile), this represents mild atrophy; whole brain volume measures 955,848 mm³, 7.1% below the reference mean. With a Z-score of -0.93 (17.5th percentile), this represents normal volume ; entorhinal cortex volume measures 3,970 mm³, 0.0% above the reference mean. With a Z-score of 0.00 (50.1th percentile), this represents normal volume ; fusiform gyrus volume measures 16,471 mm³, 8.8% below the reference mean. With a Z-score of -0.76 (22.2th percentile), this represents normal volume ; middle temporal gyrus volume measures 16,701 mm³, 17.2% below the reference mean. With a Z-score of -1.54 (6.1th percentile), this represents moderate atrophy. ",
  "text_data": "Age is 84.4 years. Gender is Male. Education: 20 years. MMSE: 26.0. MoCA: 23.0. Logical Memory: 12.0. APOEε4 alleles: 0.0. Biomarker levels: Florbetapir (AV45): 1.47 SUVR (profound elevated); Amyloid beta: 1082.00 pg/mL (normal ); Total tau: 330.60 pg/mL (mild elevated); Phosphorylated tau: 34.95 pg/mL (moderate elevated). ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "Reasoning: The hippocampal volume shows mild atrophy (Z-score -1.01, 15.7th percentile), and the middle temporal gyrus exhibits moderate atrophy (Z-score -1.54, 6.1th percentile). While MMSE (26) and MoCA (23) scores are borderline, the biomarker profile (normal Aβ, elevated T-tau and P-tau, profound AV45 elevation) strongly suggests Alzheimer’s pathology.  \n\nDiagnosis: **Mild Cognitive Impairment (MCI)** (likely due to Alzheimer’s disease)  \nConfidence: **High**  \n\n(Note: The diagnosis is MCI rather than dementia because cognitive scores remain above typical dementia thresholds, but biomarker and structural changes indicate early neurodegenerative progression.)",
  "timestamp": "2025-07-26T09:37:30.382681"
}